NCT01907685View on ClinicalTrials.gov

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Advanced Neoplastic Disease

Interventions

DRUG

AVE8062

"Pharmaceutical form:Solution for infusion~Route of administration: Intravenous"

DRUG

Docetaxel

"Pharmaceutical form: solution for infusion~Route of administration: Intravenous"

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT01907685 - Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter